02/17/2020 12:00 AM EST
Source: United Kingdom Department of Health (DH). Published: 2/17/2020. This web page, updated on February 17, 2020, links to nine resources that provide guidance to clinical diagnostic laboratories on the handling and processing of specimens associated with the 2019 novel coronavirus (COVID-19). They cover safety, laboratory investigations, and sample requirements. (Video or Multimedia)
02/16/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 2/16/2020. This web page, updated on February 16, 2020, provides guidance for laboratories' requests for 2019 novel coronavirus (COVID-19) diagnostic tools, including how to order a reagent diagnostic tool, what the diagnostic tool includes, what other equipment labs will need to perform tests using the diagnostic tool, and what safety equipment labs should use when using the diagnostic tool. (Text)
02/16/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 2/16/2020. This interim guidance is intended primarily for administrators of public and private childcare programs and K-12 schools in the United States to help prevent the introduction of the 2019 novel coronavirus (COVID-19) into their facilities. It recommends actions that school administrators should take now to help prevent the spread of COVID-19 among students and staff, and to help maintain continuity of teaching and learning if there is community spread of COVID-19 in the future. (Text)
02/14/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 2/14/2020. All U.S. hospitals need to be prepared for patients with suspected or confirmed 2019 novel coronavirus (COVID-19). This five-page checklist, updated on February 14, 2020, highlights important areas for hospitals to review in preparation for potential arrivals of COVID-19 patients. (Text)
02/14/2020 12:00 AM EST
Source: Australian Government. Published: 2/14/2020. This document, updated on February 14, 2020, is an information sheet for emergency departments about the 2019 novel coronavirus (COVID-19), including key points, the current situation, how to identify symptoms and exposure history, and actions for patients who meet the criteria. These criteria will be revised by public health authorities as more precise information emerges on the outbreak, including characteristics of transmission, incubation and infectivity period, and geographical spread. (PDF)
02/14/2020 12:00 AM EST
Source: Australian Government. Published: 2/14/2020. This document, updated on February 14, 2020, is an information sheet for primary and community health workers about the 2019 novel coronavirus (COVID-19), including key points, the current situation, how to identify symptoms and exposure history, and actions for patients who meet the criteria. These criteria will be revised by public health authorities as more precise information emerges on the outbreak, including characteristics of transmission, incubation and infectivity period, and geographical spread. (PDF)
02/14/2020 12:00 AM EST
Source: World Health Organization, Regional Office for the Western Pacific. Published: 2/14/2020. This six-page document aims to provide Pacific authorities with guidance on priority areas and actions to prepare for potential cases of COVID-19 (2019 novel coronavirus). It lists priority actions aimed at active surveillance, managing severe cases, preventing onward transmission, alleviating strain on health facilities/services, effective public communication, and reducing overall social and economic impact. (PDF)
02/14/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 2/14/2020. This web page provides answers to frequently asked questions about 2019 novel coronavirus (COVID-19) and pregnancy, under these topics: Pregnant women; transmission during pregnancy or during delivery; infants; and transmission through breastmilk. (Text)
02/14/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 2/14/2020. These guidelines for laboratories on 2019 novel coronavirus (COVID-19) were updated on February 14, 2020, to reflect appropriate specimen collection guidance for Persons Under Investigation (PUIs); removal of serum guidance; and COVID-19 terminology. (Text)
02/14/2020 12:00 AM EST
Source: World Health Organization (WHO). Published: 2/14/2020. The purpose of this nine-page document is to outline key planning considerations for organizers of mass gatherings in the context of the 2019 novel coronavirus (COVID-19) outbreak. It should be read in conjunction with the World Health Organization document Public Health for Mass Gatherings: Key Considerations, which provides general advice on the public health aspects of mass gathering events. (PDF)
02/12/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 2/12/2020. This interim guidance, updated on February 12, 202, is based on what is currently known about 2019 novel coronavirus (COVID-19) and transmission of other viral respiratory infections. It is for people with confirmed or suspected COVID-19 infection (including persons under investigation) who do not need to be hospitalized; and people with confirmed COVID-19 infection who were hospitalized and determined to be medically stable to go home. (Text)
02/12/2020 12:00 AM EST
Source: United Kingdom Department of Health (DH). Published: 2/12/2020. This one-page document, updated on February 12, 2020, is Form (E28) for requesting testing for the 2019 novel coronavirus (COVID-19). It is to be sent to the United Kingdom Respiratory Virus Unit. (PDF)
02/12/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 2/12/2020. This interim guidance is for clinicians caring for patients with confirmed 2019 novel coronavirus (2019-nCoV/COVID-19) infection. This update includes additional information regarding time from illness onset to hospital admission, and detection of 2019-nCoV in extrapulmonary specimens. It clarifies the type of advanced support observed among hospitalized patients, and provides interim guidance for discontinuation of transmission-based precautions and in-home isolation. (Text)
02/08/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 2/8/2020. This web page offers guidance on how to optimize supplies of N95 filtering facepiece respirators (commonly called “N95 respirators”) in healthcare settings in the face of potential ongoing 2019 novel coronavirus (COVID-19) transmission in the United States. The recommendations are intended for use by professionals who manage respiratory protection programs, occupational health services, and infection prevention programs in healthcare institutions to protect healthcare personnel from job-related risks of exposure to infectious respiratory illnesses. Topics are Engineering Controls; Administrative Controls; and Personal Protective Equipment and Respiratory Protection. (Text)
02/07/2020 12:00 AM EST
Source: World Health Organization (WHO). Published: 2/7/2020. This two-page document for laboratories is the shipment booking form for 2019 novel coronavirus (COVID-19) specimens, isolates, or cultures being shipped to the World Health Organization. (PDF)
02/06/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 2/6/2020. This eight-page Case Report Form is intended for local and state health departments who have a laboratory confirmed case of 2019 novel coronavirus (COVID-19) to report to the Centers for Disease Control and Prevention. The form provides a standardized approach to collecting data in order to track the outbreak, better characterize cases, and inform the public health response. (PDF)
02/04/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention (CDC). Published: 2/4/2020. This two-page fact sheet is for patients whose sample(s) were tested for the 2019 novel coronavirus (COVID-19) using the Centers for Disease Control and Prevention (CDC) 2019-nCoV Real-Time RT-PCR Diagnostic Panel. It contains information to help patients understand the risks and benefits of using this test for the diagnosis of 2019-nCoV infection. (PDF)
02/04/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention (CDC). Published: 2/4/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Centers for Disease Control and Prevention (CDC) 2019-nCoV Real-Time RT-PCR Diagnostic Panel. This test is to be performed only using respiratory specimens collected from individuals who meet CDC criteria for 2019 novel coronavirus (COVID-19) testing. (Text)
02/01/2020 12:00 AM EST
Source: World Health Organization (WHO). Published: 2/2020. All personnel responding to outbreaks of acute respiratory infections (ARIs) need to have the basic knowledge and skills to mount an effective response. They need to understand what ARIs are, how they are transmitted, how to assess the risk of infection, and to understand basic hygiene measures to protect themselves. This learning package consists of four modules with videos and downloadable presentations. (Video or Multimedia)
02/01/2020 12:00 AM EST
Source: Center for Global Development (CGD). Published: 2/2020. This four-page paper recommends actions to address pressing gaps in U.S. and global preparedness in the event that COVID-19 (2019 novel coronavirus) cannot be contained, and sustained human-to-human transmission occurs beyond China. It discusses how the U.S, in particular, should not assume it is immune to a major domestic outbreak, and why these recommendations are critical both for this outbreak and for future epidemic threats. (PDF)
02/01/2020 12:00 AM EST
Source: Boston Public Health Commission, Office of Public Health Preparedness, DelValle Institute for Emergency Preparedness. Published: 2/2020. This course provides an overview of the Emergency Operations Plan (EOP) planning process and summarizes federal guidance and other best practices. Learners will be able to describe the function of an EOP; describe how to organize the process of developing an EOP; describe the structure of an EOP for healthcare organizations and define its key components; and describe how to implement and maintain the EOP. (Video or Multimedia)
02/01/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention, Center for Preparedness and Response (CDC CPR). Published: 2/1/2020. This Centers for Disease Control and Prevention Health Alert Network (HAN) Update provides a situational update and interim guidance to state and local health departments for the 2019 novel coronavirus (2019-nCoV/COVID-19). It includes Recommendations for Screening of Patients for 2019-nCoV in Healthcare Facilities, Criteria to Guide Evaluation and Testing of Patients Under Investigation (PUI) for 2019-nCoV, and Recommendations for Healthcare Providers. (Text)
01/30/2020 12:00 AM EST
Source: Save the Children International. Published: 1/30/2020. This webinar presents the fundamentals of inclusive planning and why planning for the needs of children with disabilities, access, or functional needs before, during, and after disasters ultimately benefits the entire community and its ability to recover. It discusses whole community inclusion, disability civil rights, disability inclusive emergency management, and emergency planning and disaster resilience. (Video or Multimedia)
12/10/2019 12:00 AM EST
Source: North Dakota Public Health Training Network (NDPHTN). Published: 12/10/2019. This course includes objectives to define the National Incident Management System (NIMS) and the National Response Framework (NRF); review the Incident Command chain of command; review the predesignated incident facilities; discuss Incident Command modularity, expansion, contraction, and activation; define the difference between unified command, unity of command, and area command; and review the three incident command priorities. (Video or Multimedia)
12/01/2019 12:00 AM EST
Source: World Health Organization (WHO). Published: 12/2019. This 12-page report summarizes the World Health Organization (WHO) team of international experts' biosafety and biosecurity inspection in May 2019 at the Centers for Disease Control and Prevention (CDC), one of the two World Health Organization authorized variola virus (causative agent of smallpox) repositories. Since the last inspection in 2017, CDC has made significant improvements, with many previous findings addressed and closed. (PDF)
12/01/2019 12:00 AM EST
Source: World Health Organization (WHO). Published: 12/2019. This 12-page report summarizes the World Health Organization (WHO) team of international experts' biosafety and biosecurity inspection at the Federal Budgetary Research Institution-State Research Centre of Virology and Biotechnology of the Federal Service for Surveillance on Consumer Rights Protection and Human Well-Being (VECTOR) in Russia, one of the two WHO-authorized variola virus (causative agent of smallpox) repositories. Since the last inspection in 2016, VECTOR has made significant improvements, with many previous findings addressed and closed. (PDF)
10/16/2019 12:00 AM EDT
Source: Center for Global Development (CGD). Published: 10/16/2019. This report discusses how impending leadership transitions in European Union (EU) institutions provide a unique opportunity to bolster European action on global health security. In the areas of health security, pandemic preparedness operations, and financing at the pan European and global levels, the new European Commission should seize the opportunity for strengthened cohesion and priority setting with Member States. The report provides recommendations and actions to achieve these goals. (Text)
No hay comentarios:
Publicar un comentario